Hans-Peter Hartung, MD, PhD, FRCP, is Director of the Center for Neuropsychiatry and Chair of the Department of Neurology at Heinrich Heine University Düsseldorf, Germany. He is in charge of two busy inpatient departments with a total of 100 beds including a supraregional comprehensive stroke unit.
Professor Hartung’s clinical and translational research interests are in the field of basic and clinical neuroimmunology, in particular multiple sclerosis (MS) and immune neuropathies. He oversees the various clinical and preclinical research activities in his department relating to Parkinson’s and movement disorders. He has been a Steering Committee member for numerous international phase II and III trials in MS, Guillain-Barré Syndrome and chronic inflammatory demyelinating polyneuropathy.
Professor Hartung was President of ECTRIMS and is a member of a large number of international professional societies, serving on executive boards for the European Charcot Foundation, the International Society of Neuroimmunology, European School of Neuroimmunology, European Neurological Society, Peripheral Nerve Society, WHO Working Group on Multiple Sclerosis, GBS Foundation International, the Medical Advisory Board of the International and the German MS Society, and the US NMS Society. Professor Hartung has been on the Editorial Board of a number of international journals, and has authored or co-authored more than 900 articles in peer-reviewed journals and 100 book chapters, and edited nine books.
Honoraria or consultation fees from Bayer Healthcare GmbH, Biogen, GeNeuro, Genzyme, F. Hoffmann-La Roche, MedImmune, Merck Serono, Novartis, Sanofi Aventis, and Teva.